1. HBW Insight
  2. >>Geography
  3. >>Europe

Norway's OTC Market In 2018: Sales Remain Stable As GSK Consolidates Its Leading Position

 
• By Tom Gallen

Sales of non-prescription medicines in Norway edged up by less than 1% in 2018, as GSK remained the leading player on the market and its Otrivin respiratory line maintained its position as the country's best-selling OTC brand. 

Norway flag
• Source: Shutterstock

Norway’s market for non-prescription medicines remained roughly stable in 2018, according to figures from local pharmaceutical industry association Legemiddelindustrien (LMI) and Farmastat.

Sales of non-prescription products over the 12 months edged up by 0.3% to NOK1.45bn ($170m) at pharmacy purchase prices

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography